In the realm of pharmaceutical manufacturing and drug discovery, the quality and utility of chemical intermediates are fundamental. D-Phenylglycinamide, identified by CAS number 6485-67-2, is a prominent chiral amine that serves as a critical intermediate in the synthesis of various therapeutic compounds. Its specific stereochemistry and reactivity make it an indispensable building block for complex molecule construction. This article explores the synthetic utility of D-Phenylglycinamide, highlighting its importance in pharmaceutical R&D and production.

The chemical structure of D-Phenylglycinamide, (2R)-2-amino-2-phenylacetamide, provides the essential chiral center and functional groups required for specific coupling and derivatization reactions. This makes it a preferred starting material for synthesizing molecules where precise stereochemical control is necessary. Its application is notably recognized in the synthesis of Boceprevir, a potent inhibitor of the Hepatitis C virus protease. The successful integration of D-Phenylglycinamide into such complex synthetic pathways underscores its value to the pharmaceutical industry.

For R&D scientists and procurement professionals, understanding the role of D-Phenylglycinamide as a pharmaceutical intermediate is key. When looking to purchase this compound, emphasis should be placed on its purity and consistent quality. Sourcing from a reputable manufacturer ensures that the material meets stringent standards required for drug synthesis. Factors such as high purity (>97%), proper storage conditions (cool, dark, inert atmosphere), and detailed Certificates of Analysis are crucial indicators of a reliable supply. Exploring various suppliers and comparing their offerings, including the D-Phenylglycinamide price, can help optimize the procurement process.

The demand for high-quality chiral intermediates like D-Phenylglycinamide continues to grow as pharmaceutical research explores increasingly complex molecular structures. Reliable sourcing from companies that specialize in producing and distributing these fine chemicals is therefore essential for maintaining efficient research and manufacturing operations. Whether for early-stage drug discovery or large-scale API production, securing a consistent supply of D-Phenylglycinamide from trusted sources is paramount.

In conclusion, D-Phenylglycinamide is a vital component in the pharmaceutical synthesis toolkit. Its unique chiral properties and proven application in drug manufacturing make it a sought-after intermediate. By focusing on quality, purity, and reliable supply chains from established chemical companies, the industry can leverage this compound to accelerate the development of new and effective therapies.